TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 295 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $95,652 | +108.0% | 6,183 | +111.2% | 0.00% | – |
| Q2 2023 | $45,984 | -8.7% | 2,927 | -4.3% | 0.00% | -100.0% |
| Q1 2023 | $50,380 | +15.7% | 3,057 | +9.5% | 0.00% | – |
| Q4 2022 | $43,540 | +17.7% | 2,791 | -2.8% | 0.00% | – |
| Q3 2022 | $37,000 | +362.5% | 2,871 | +435.6% | 0.00% | – |
| Q2 2022 | $8,000 | +700.0% | 536 | +665.7% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 70 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 70 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 70 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 70 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 70 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 70 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | -75.0% | 70 | -64.3% | 0.00% | – |
| Q2 2020 | $4,000 | +300.0% | 196 | +180.0% | 0.00% | – |
| Q1 2020 | $1,000 | 0.0% | 70 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | 0.0% | 70 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 70 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | 0.0% | 70 | 0.0% | 0.00% | – |
| Q1 2019 | $1,000 | – | 70 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |